Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand

December 2, 2010 updated by: AstraZeneca

Asthma Control Among Patients Who Were Receiving Inhaled Corticosteroids in General Practice in Thailand

The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Anticipated)

1210

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Thailand
      • Amnat Charoen, Thailand
        • Research Site
      • Buriram, Thailand
        • Research Site
      • Chachoengsao, Thailand
        • Research Site
      • Chaiyaphum, Thailand
        • Research Site
      • Chanthaburi, Thailand
        • Research Site
      • Chiang Rai, Thailand
        • Research Site
      • Kalasin, Thailand
        • Research Site
      • Khon Kaen, Thailand
        • Research Site
      • Lopburi, Thailand
        • Research Site
      • Mae Hong Son, Thailand
        • Research Site
      • Mahasarakham, Thailand
        • Research Site
      • Nakhon Phanom, Thailand
        • Research Site
      • Nakhorn Ratchasima, Thailand
        • Research Site
      • Nan, Thailand
        • Research Site
      • Nong Khai, Thailand
        • Research Site
      • Samutsongkhram, Thailand
        • Research Site
      • Si Sa Ket, Thailand
        • Research Site
      • Singburi, Thailand
        • Research Site
      • Songkla, Thailand
        • Research Site
      • Sukhothai, Thailand
        • Research Site
      • Surat Thani, Thailand
        • Research Site
      • Trang, Thailand
        • Research Site
      • Trat, Thailand
        • Research Site
      • Ubon Ratchathani, Thailand
        • Research Site
      • Udon Thani, Thailand
        • Research Site
      • Yasothon, Thailand
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient aged 12 years and older who established persistent asthma and currently treated with any inhaled corticosteroid for 3 months or longer.

Description

Inclusion Criteria:

  • Established persistent asthma
  • Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer

Exclusion Criteria:

  • Currently participating or have participated in a study with an investigational compound within the last 30 days
  • Current diagnosis of chronic obstructive pulmonary disease (COPD)
  • Smoked more than 10 packs a year

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Asthma control test
Time Frame: On the survey date
On the survey date

Secondary Outcome Measures

Outcome Measure
Time Frame
Asthma control in mild, moderate and severe persistent asthma patients
Time Frame: On the survey date
On the survey date

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Investigators

  • Principal Investigator: Bandit Thinkhamrop, PhD, Department of Biostatistics and Demography, Faculty of Public Health, Khon Kaen University
  • Principal Investigator: Watchara Boonsawat, MD. PhD, Department of Medicine, Faculty of Medicine, Khon Kaen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2009

Study Completion (Actual)

November 1, 2009

Study Registration Dates

First Submitted

December 1, 2008

First Submitted That Met QC Criteria

December 1, 2008

First Posted (Estimate)

December 2, 2008

Study Record Updates

Last Update Posted (Estimate)

December 3, 2010

Last Update Submitted That Met QC Criteria

December 2, 2010

Last Verified

December 1, 2010

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIS-RTH-DUM-2008/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe